DrugPatentWatch Database Preview
Drugs in MeSH Category Antirheumatic Agents
Email this page to a colleague
» See Plans and Pricing| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-003 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Watson Labs | SULFASALAZINE | sulfasalazine | TABLET, DELAYED RELEASE;ORAL | 088052-001 | May 24, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Teva Pharms Usa | COPAXONE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 020622-002 | Feb 12, 2002 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Allergan | RESTASIS MULTIDOSE | cyclosporine | EMULSION;OPHTHALMIC | 050790-002 | Oct 27, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Baxter Hlthcare | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 040745-002 | May 21, 2008 | AP | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Pharmacia And Upjohn | AZULFIDINE EN-TABS | sulfasalazine | TABLET, DELAYED RELEASE;ORAL | 007073-002 | Apr 6, 1983 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
